ArticleEuropean journal of clinical pharmacology2020

Effects of ABCG2 and SLCO1B1 gene variants on inflammation markers in patients with hypercholesterolemia and diabetes mellitus treated with rosuvastatin.

Dan Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.